Lysergic acid diethylamide

Generic Name
Lysergic acid diethylamide
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C20H25N3O
CAS Number
50-37-3
Unique Ingredient Identifier
8NA5SWF92O
Background

Debate continues over the nature and causes of chronic flashbacks. Explanations in terms of LSD physically remaining in the body for months or years after consumption have been discounted by experimental evidence. Some say HPPD is a manifestation of post-traumatic stress disorder, not related to the direct action of LSD on brain chemistry, and varies accordi...

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin

Early Phase 1
Completed
Conditions
Healthy
Interventions
Drug: LSD
Drug: Psilocybin
First Posted Date
2018-07-27
Last Posted Date
2021-04-27
Lead Sponsor
University Hospital, Basel, Switzerland
Target Recruit Count
28
Registration Number
NCT03604744
Locations
🇨🇭

Clinical Pharmacology & Toxicology, University Hospital Basel, Basel, Switzerland

Role of the Serotonin 5-HT2A Receptor in LSD-induced Altered States of Consciousness (LDR-Study)

Early Phase 1
Completed
Conditions
Healthy
Interventions
Drug: LSD
Drug: Placebo
First Posted Date
2017-10-25
Last Posted Date
2019-08-28
Lead Sponsor
University Hospital, Basel, Switzerland
Target Recruit Count
16
Registration Number
NCT03321136
Locations
🇨🇭

University Hospital, Basel, Switzerland

LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders

Phase 2
Completed
Conditions
Patients
Anxiety Disorders
Interventions
Drug: Placebo
Drug: LSD
First Posted Date
2017-05-15
Last Posted Date
2021-12-22
Lead Sponsor
University Hospital, Basel, Switzerland
Target Recruit Count
46
Registration Number
NCT03153579
Locations
🇨🇭

University Hospital Basel, Basel, BS, Switzerland

🇨🇭

Private Practice P.Gasser, Solothurn, SO, Switzerland

Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion Processing

Early Phase 1
Completed
Conditions
Healthy
Interventions
Drug: LSD
Drug: MDMA
Drug: Amphetamine
Drug: Placebo
First Posted Date
2017-01-13
Last Posted Date
2018-10-15
Lead Sponsor
University Hospital, Basel, Switzerland
Target Recruit Count
28
Registration Number
NCT03019822
Locations
🇨🇭

University Hospital Basel, Basel, Basel Stadt, Switzerland

The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy Volunteers

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Placebo
Drug: LSD
Drug: Ketanserin
First Posted Date
2015-05-21
Last Posted Date
2016-02-01
Lead Sponsor
Psychiatric University Hospital, Zurich
Target Recruit Count
25
Registration Number
NCT02451072
Locations
🇨🇭

Center for Psychiatric Research, Department of Psychiatry, Psychotherapy and Psychosomatic, Psychiatric Hospital, University of Zurich, Zurich, Switzerland

Neuronal Correlates of Altered States of Consciousness

Early Phase 1
Completed
Conditions
Healthy
Interventions
Drug: LSD
Drug: Placebo
First Posted Date
2014-12-05
Last Posted Date
2015-09-25
Lead Sponsor
University Hospital, Basel, Switzerland
Target Recruit Count
24
Registration Number
NCT02308969
Locations
🇨🇭

University Hospital, Basel, Switzerland

Psychological, Physiological, Endocrine, and Pharmacokinetic Effects of LSD in a Controlled Study

Early Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
Drug: LSD
First Posted Date
2013-06-17
Last Posted Date
2016-01-21
Lead Sponsor
University Hospital, Basel, Switzerland
Target Recruit Count
16
Registration Number
NCT01878942
Locations
🇨🇭

University Hospital Basel, Basel, Basel-Stadt, Switzerland

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy